Ebos GroupASX:EBO +0.30%77 Market Cap is A$3,465 Mil as of Jun. 27, 2026. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$31.49 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 122 Medical Distribution companies, Ebos Group ranks better than 86.89% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ebos Group's share price for the quarter that ended in Dec. 2025 was A$23.64. Ebos Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 205 Mil. Therefore, Ebos Group's market cap for the quarter that ended in Dec. 2025 was A$4,847 Mil.
Ebos Group's quarterly market cap
increased
from Dec. 2024 (A$6,617 Mil) to Jun. 2025 (A$7,233 Mil) but then
declined
from Jun. 2025 (A$7,233 Mil) to Dec. 2025 (A$4,847 Mil).
Ebos Group's annual market cap
declined
from Jun. 2023 (A$6,470 Mil) to Jun. 2024 (A$5,780 Mil) but then
increased
from Jun. 2024 (A$5,780 Mil) to Jun. 2025 (A$7,233 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ebos Group's Enterprise Value for Today is A$4,931 Mil.
Ebos Group (ASX:EBO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ebos Group Market Cap Related Terms
Ebos Group Market Cap Historical Data
* Premium members only.
The historical data trend for Ebos Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Ebos Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ebos Group's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) has a Market Cap of A$3,465 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ebos Group and its competitors. According to the industry distribution chart, Ebos Group ranks #16 out of 122 companies in the Medical Distribution industry, placing it in the top 13.1%.
Is Ebos Group's Market Cap too high?
Ebos Group's current Market Cap is A$3,465 Mil. Based on the distribution chart, Ebos Group ranks #16 out of 122 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #16 out of 122 companies for Market Cap. This places Ebos Group in the top 13% of its industry — outperforming the majority of peers. The industry median Market Cap is 137.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 137.62, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median Market Cap is 137.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current Market Cap is A$3,465 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.49, compared to a current price of A$16.76 — trading 46.8% below its estimated fair value. The current Market Cap is A$3,465 Mil. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current Market Cap is A$3,465 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$16.76 is trading 46.8% below its estimated GF Value™ of A$31.49.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
Market Cap: A$3,465 Mil
GF Value™: A$31.49 vs. price of A$16.76 (46.8% below fair value)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 
